Doctors have used focused ultrasound to destroy tumors without invasive surgery for some time. However, the therapeutic ultrasound used in clinics today indiscriminately damages cancer and healthy cells alike. Researchers have now developed a low-intensity ultrasound approach that exploits the properties of tumor cells to target them and provide a safer option. Their findings, reported in Applied Physics Letters, are a new step in oncotripsy, the singling out and killing of cancer cells based on their physical properties.
Tag: Cancer Treatment
Survey finds 1 in 3 patients needed more information on cancer treatment side effects
One in three adults treated for cancer may experience side effects from treatment they wish they had known more about, according to a new survey published in the Journal of Oncology Practice. The national survey of more than 400 U.S. adults, which was sponsored by the American Society for Radiation Oncology (ASTRO), also found that nine in 10 patients felt they made the right treatment decision despite the desire for more information about treatment side effects.
Receiving care in a multidisciplinary prostate cancer clinic increases discussion about treatment options and adherence to national guidelines
Newly diagnosed prostate cancer patients have multiple standard-of-care treatment options available, but many are not fully informed of their choices. A study led by researchers at The University of Texas MD Anderson Cancer Center found men who seek treatment at a multidisciplinary (MultiD) prostate cancer clinic are more likely to be advised about treatment choices and to receive care that complies with evidence-based treatment guidelines.
MD Anderson, Artios Pharma and ShangPharma announce in-licensing agreement for DNA damage response inhibitor
MD Anderson, Artios and ShangPharma have announced the in-licensing by Artios of a small-molecule ATR inhibitor program, developed jointly by MD Anderson and ShangPharma.
MD Anderson and Takeda Announce Collaboration to Accelerate the Development of Clinical-Stage, Off-The-Shelf CAR NK-Cell Therapy Platform
MD Anderson and Takeda today announced an exclusive license agreement and research agreement to develop CAR NK-cell therapies for the the treatment of B-cell malignancies.
Using Plasma Jets to Deliver Cancer Medication
Modern advances in oncology have significantly improved cancer survival rates. However, personalized treatment methods are necessary, since tumors may behave differently for different patients. At the AVS 66th International Symposium and Exhibition, Cristina Canal, a researcher at Universitat Politècnica de Catalunya, will present cold plasmas as a promising tool for minimally invasive cancer therapy. She will discuss the benefits of using plasma jets for cancer therapy, and explain the use of different liquid media, hydrogels and their properties.
Vaccine to Block Digestive Hormone May Slow Growth of Pancreatic Cancer
New research suggests a vaccine that blocks a digestive hormone may slow the spread of pancreatic cancer, potentially increasing survival rates. The study, published ahead of print in the American Journal of Physiology—Gastrointestinal and Liver Physiology, was chosen as an APSselect article for October.
Bone filler device accelerates bone healing in difficult cases
A new approach may boost the bone repair process for those who have just a 20% chance of a broken bone healing.
Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer
Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer. Pegilodecakin with pembrolizumab and nivolumab shown to be safe in Phase IB study
Taking Baby Aspirin Improves Overall Survival for Patients With Head & Neck, Lung Cancer
In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients with some head/neck and lung cancers.
Henry Ford Cancer Institute First-in-Michigan, Second-in-World to Complete Laser Spinal Ablation
Henry Ford Cancer Institute is the first-in-Michigan and second-in-the-world to complete an innovative cancer treatment known as Spinal Laser Interstitial Thermal Therapy (SLITT), which destroys cancer cells that are adjacent to the spine without the need for open surgery.
Depression, Anxiety Linked to Opioid Use in Women With Breast Cancer
The findings should encourage doctors to better manage mental health in patients with breast cancer and spur care providers to consider alternative pain management such as physical therapy, massage and acupuncture, the researchers say.
Depression, Anxiety Linked to Opioid Use in Women With Breast Cancer
The findings should encourage doctors to better manage mental health in patients with breast cancer and spur care providers to consider alternative pain management such as physical therapy, massage and acupuncture, the researchers say.
Boehringer Ingelheim and MD Anderson form unique virtual research and development center to rapidly advance new cancer therapies
Boehringer Ingelheim and MD Anderson have announced a new multi-year partnership to conduct collaborative research, combining the drug-development capabilities of MD Anderson with the pipeline of novel medicines from Boehringer Ingelheim.
RWJBarnabas Health and Rutgers Cancer Institute Announce New $750 Million, Free-Standing Cancer Pavilion in New Brunswick
NEW BRUNSWICK, N.J., June 19, 2019 – RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, in partnership with New Brunswick Development Corporation have announced the development of a new, state-of-the-art, free-standing cancer pavilion in New Brunswick. The initial estimated…